{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T13:05:10Z","timestamp":1748869510831},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,29]]},"DOI":"10.7759\/cureus.31999","type":"journal-article","created":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T08:27:46Z","timestamp":1669710466000},"source":"Crossref","is-referenced-by-count":1,"title":["Anaplastic Transformation of Follicular Thyroid Carcinoma in Pulmonary Metastasis With Gradually Progressive Intra-tumoral Cavitation: A Case Report"],"prefix":"10.7759","author":[{"given":"Hajime","family":"Torizuka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Iizuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Mizowaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung H","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021, 71:209-49. 10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12515","article-title":"Guidelines for the management of thyroid cancer","volume":"81 Suppl 1","author":"Perros P","year":"2014","unstructured":"Perros P, Boelaert K, Colley S, et al.. Guidelines for the management of thyroid cancer. Clin Endocrinol (Oxf). 2014, 81 Suppl 1:1-122. 10.1111\/cen.12515","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1530\/EDM-19-0085","article-title":"Anaplastic thyroid carcinoma diagnosed after treatment of lenvatinib for papillary thyroid carcinoma","volume":"2019","author":"Yamazaki H","year":"2019","unstructured":"Yamazaki H, Iwasaki H, Suganuma N, et al.. Anaplastic thyroid carcinoma diagnosed after treatment of lenvatinib for papillary thyroid carcinoma. Endocrinol Diabetes Metab Case Rep. 2019, 2019:10.1530\/EDM-19-0085","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-021-09674-1","article-title":"Progression of papillary thyroid carcinoma to anaplastic carcinoma in metastatic lymph nodes: solid\/insular growth and hobnail cell change in lymph nodes are predictors of subsequent anaplastic transformation","volume":"32","author":"Odate T","year":"2021","unstructured":"Odate T, Oishi N, Kawai M, et al.. Progression of papillary thyroid carcinoma to anaplastic carcinoma in metastatic lymph nodes: solid\/insular growth and hobnail cell change in lymph nodes are predictors of subsequent anaplastic transformation. Endocr Pathol. 2021, 32:347-56. 10.1007\/s12022-021-09674-1","journal-title":"Endocr Pathol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s40792-020-00959-x","article-title":"Anaplastic transformation of thyroid cancer in mesentery metastases presenting as intestinal perforation: a case report","volume":"6","author":"Hosoda K","year":"2020","unstructured":"Hosoda K, Kusama K, Yanagisawa N, et al.. Anaplastic transformation of thyroid cancer in mesentery metastases presenting as intestinal perforation: a case report. Surg Case Rep. 2020, 6:194. 10.1186\/s40792-020-00959-x","journal-title":"Surg Case Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2020.3362","article-title":"Evaluation of overall survival in patients with anaplastic thyroid carcinoma, 2000-2019","volume":"6","author":"Maniakas A","year":"2020","unstructured":"Maniakas A, Dadu R, Busaidy NL, et al.. Evaluation of overall survival in patients with anaplastic thyroid carcinoma, 2000-2019. JAMA Oncol. 2020, 6:1397-404. 10.1001\/jamaoncol.2020.3362","journal-title":"JAMA Oncol"},{"key":"ref7","article-title":"Anaplastic thyroid carcinoma","author":"Lloyd RV","year":"2017","unstructured":"Lloyd RV, Osamura RY, Kloppel G, Rosai J. Anaplastic thyroid carcinoma. WHO Classification of Tumours of Endocrine Organs. Lloyd RV, Osamura RY, Kloppel G, Rosai J (ed): World Health Organization, Geneva, Switzerland; 2017. 10:104-6."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/674583","article-title":"Anaplastic thyroid cancer: the addition of systemic chemotherapy to radiotherapy led to an observed improvement in survival--a single centre experience and review of the literature","volume":"2014","author":"Lowe NM","year":"2014","unstructured":"Lowe NM, Loughran S, Slevin NJ, Yap BK. Anaplastic thyroid cancer: the addition of systemic chemotherapy to radiotherapy led to an observed improvement in survival--a single centre experience and review of the literature. ScientificWorldJournal. 2014, 2014:674583. 10.1155\/2014\/674583","journal-title":"ScientificWorldJournal"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.142.8.717","article-title":"Identification of molecular markers altered during transformation of differentiated into anaplastic thyroid carcinoma","volume":"142","author":"Wiseman SM","year":"2007","unstructured":"Wiseman SM, Griffith OL, Deen S, et al.. Identification of molecular markers altered during transformation of differentiated into anaplastic thyroid carcinoma. Arch Surg. 2007, 142:717-27; discussion 727-9. 10.1001\/archsurg.142.8.717","journal-title":"Arch Surg"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/241308","article-title":"Anaplastic transformation of papillary thyroid cancer in the retroperitoneum","volume":"2015","author":"Solomon JP","year":"2015","unstructured":"Solomon JP, Wen F, Jih LJ. Anaplastic transformation of papillary thyroid cancer in the retroperitoneum. Case Rep Pathol. 2015, 2015:241308. 10.1155\/2015\/241308","journal-title":"Case Rep Pathol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1126\/science.275.5299.547","article-title":"Tumor infarction in mice by antibody-directed targeting of tissue factor to tumor vasculature","volume":"275","author":"Huang X","year":"1997","unstructured":"Huang X, Molema G, King S, Watkins L, Edgington TS, Thorpe PE. Tumor infarction in mice by antibody-directed targeting of tissue factor to tumor vasculature. Science. 1997, 275:547-50. 10.1126\/science.275.5299.547","journal-title":"Science"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.55.7155","article-title":"A rupture of a lung metastatic lesion of colon cancer, leading to pneumothorax caused by bevacizumab","volume":"55","author":"Iida T","year":"2016","unstructured":"Iida T, Yabana T, Nakagaki S, Adachi T, Kondo Y. A rupture of a lung metastatic lesion of colon cancer, leading to pneumothorax caused by bevacizumab. Intern Med. 2016, 55:3125-9. 10.2169\/internalmedicine.55.7155","journal-title":"Intern Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.21037\/gs-22-71","article-title":"Lung cavitation in patients with anaplastic thyroid cancer treated with lenvatinib","volume":"11","author":"Murayama D","year":"2022","unstructured":"Murayama D, Yamamoto Y, Matsui A, Yasukawa M, Okamoto S, Toda S, Iwasaki H. Lung cavitation in patients with anaplastic thyroid cancer treated with lenvatinib. Gland Surg. 2022, 11:963-9. 10.21037\/gs-22-71","journal-title":"Gland Surg"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1501993","article-title":"Biologic and clinical perspectives on thyroid cancer","volume":"375","author":"Fagin JA","year":"2016","unstructured":"Fagin JA, Wells SA Jr. Biologic and clinical perspectives on thyroid cancer. N Engl J Med. 2016, 375:1054-67. 10.1056\/NEJMra1501993","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1210\/er.2019-00007","article-title":"Targeted therapy for advanced thyroid cancer: kinase inhibitors and beyond","volume":"40","author":"Cabanillas ME","year":"2019","unstructured":"Cabanillas ME, Ryder M, Jimenez C. Targeted therapy for advanced thyroid cancer: kinase inhibitors and beyond. Endocr Rev. 2019, 40:1573-604. 10.1210\/er.2019-00007","journal-title":"Endocr Rev"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.clon.2010.03.013","article-title":"Anaplastic thyroid carcinoma: pathogenesis and emerging therapies","volume":"22","author":"Smallridge RC","year":"2010","unstructured":"Smallridge RC, Copland JA. Anaplastic thyroid carcinoma: pathogenesis and emerging therapies. Clin Oncol (R Coll Radiol). 2010, 22:486-97. 10.1016\/j.clon.2010.03.013","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-1520","article-title":"A multiinstitutional phase 2 trial of pazopanib monotherapy in advanced anaplastic thyroid cancer","volume":"97","author":"Bible KC","year":"2012","unstructured":"Bible KC, Suman VJ, Menefee ME, et al.. A multiinstitutional phase 2 trial of pazopanib monotherapy in advanced anaplastic thyroid cancer. J Clin Endocrinol Metab. 2012, 97:3179-84. 10.1210\/jc.2012-1520","journal-title":"J Clin Endocrinol Metab"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2012.0103","article-title":"Phase II trial of sorafenib in patients with advanced anaplastic carcinoma of the thyroid","volume":"23","author":"Savvides P","year":"2013","unstructured":"Savvides P, Nagaiah G, Lavertu P, et al.. Phase II trial of sorafenib in patients with advanced anaplastic carcinoma of the thyroid. Thyroid. 2013, 23:600-4. 10.1089\/thy.2012.0103","journal-title":"Thyroid"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.03093","article-title":"Open-label, single-arm, multicenter, Phase II trial of lenvatinib for the treatment of patients with anaplastic thyroid cancer","volume":"39","author":"Wirth LJ","year":"2021","unstructured":"Wirth LJ, Brose MS, Sherman EJ, et al.. Open-label, single-arm, multicenter, Phase II trial of lenvatinib for the treatment of patients with anaplastic thyroid cancer. J Clin Oncol. 2021, 39:2359-66. 10.1200\/JCO.20.03093","journal-title":"J Clin Oncol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2021.12.014","article-title":"Dabrafenib plus trametinib in patients with BRAF V600E-mutant anaplastic thyroid cancer: updated analysis from the phase II ROAR basket study","volume":"33","author":"Subbiah V","year":"2022","unstructured":"Subbiah V, Kreitman RJ, Wainberg ZA, et al.. Dabrafenib plus trametinib in patients with BRAF V600E-mutant anaplastic thyroid cancer: updated analysis from the phase II ROAR basket study. Ann Oncol. 2022, 33:406-15. 10.1016\/j.annonc.2021.12.014","journal-title":"Ann Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/125692-anaplastic-transformation-of-follicular-thyroid-carcinoma-in-pulmonary-metastasis-with-gradually-progressive-intra-tumoral-cavitation-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:51:01Z","timestamp":1707508261000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/125692-anaplastic-transformation-of-follicular-thyroid-carcinoma-in-pulmonary-metastasis-with-gradually-progressive-intra-tumoral-cavitation-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,29]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.31999","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11,29]]}}}